Updated July 2026 · 10 min read

Paralytics (Neuromuscular Blockers): The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Neuromuscular blocking agents — paralytics — are among the highest-alert medications a nurse ever hands over. They stop a patient from moving, which means they also stop the patient from breathing and from showing you they're in pain or awake. Handled with discipline they're a precise tool for intubation and severe ARDS; handled loosely they cause awareness, pressure injury, and prolonged weakness. Here's what every ICU nurse and CRNA student must understand.

Two families: depolarizing vs non-depolarizing

All neuromuscular blockers work at the neuromuscular junction, but through two different mechanisms.

Depolarizing (succinylcholine). Succinylcholine ("sux") mimics acetylcholine, causing an initial muscle depolarization — you'll see brief fasciculations — then flaccid paralysis. Its claim to fame is speed: onset in ~30–60 seconds and duration of only ~5–10 minutes, which is why it's a classic choice for rapid sequence intubation (RSI). It cannot be pharmacologically "reversed"; it simply wears off.

Non-depolarizing (rocuronium, vecuronium, cisatracurium). These competitively block acetylcholine at the receptor. Slower onset, longer duration, and — importantly — reversible. Rocuronium is the common RSI alternative to sux; cisatracurium is the usual choice for continuous infusions in ARDS.

The agents at a glance

Why cisatracurium for drips? It's cleared by Hofmann elimination — a spontaneous, organ-independent breakdown — so it doesn't accumulate in liver or kidney failure. That predictability makes it the preferred continuous agent in critically ill patients whose organ function is unreliable.

Succinylcholine's danger list

Monitoring: train-of-four and the sedation gap

For continuous neuromuscular blockade, depth is monitored with a peripheral nerve stimulator — the train-of-four (TOF). Four electrical stimuli are delivered and the number of muscle twitches counted; a common target for ICU paralysis is 1–2 twitches out of 4, indicating adequate but not excessive blockade. TOF prevents both under-dosing (patient movement, vent dyssynchrony) and over-dosing (drug accumulation, prolonged weakness).

But TOF tells you about muscles, not consciousness. Because a paralyzed patient can't show pain or awareness, teams increasingly use processed-EEG depth-of-sedation monitors and rigorous sedation protocols to guard against awareness under paralysis — a genuinely traumatic complication. The nurse's vigilance on the sedation side is what closes that gap.

When paralytics are actually used in the ICU

Neuromuscular blockade is targeted, not routine. Common indications include facilitating intubation, managing severe ventilator dyssynchrony that lighter measures can't fix, severe ARDS (short courses of cisatracurium in early, severe disease per protocol), controlling intracranial or intra-abdominal pressure, and shivering control during targeted temperature management. In each case the paralytic serves a specific physiologic goal and is stopped as soon as that goal is met.

Complications of prolonged paralysis

ICU-acquired weakness. Prolonged blockade, especially combined with steroids, is associated with critical illness myopathy and neuropathy — patients who are weak for weeks after. Minimizing duration matters.

Pressure injuries and corneal abrasion. A motionless patient needs meticulous repositioning, eye care/lubrication and taping, and DVT prophylaxis, because they can't shift or blink to protect themselves.

Masked seizures and masked pain. Paralysis hides both — another reason continuous sedation and clinical vigilance are mandatory.

Why CRNA students must master paralytics

Neuromuscular blockade is core anesthesia. In the OR you'll paralyze for intubation and surgical relaxation, monitor with TOF, and — crucially — reverse at the end of a case with agents like neostigmine or sugammadex (which rapidly reverses rocuronium/vecuronium). Understanding depolarizing vs non-depolarizing pharmacology, the sux contraindications, and TOF interpretation at the ICU bedside is the same skill set you'll use every day in anesthesia. For nurses on the CRNA path, this is high-yield territory.

Bottom line

Paralytics are precision tools with zero margin for a sedation lapse. Know the two drug families and their signature agents, respect succinylcholine's hyperkalemia and malignant-hyperthermia risks, monitor depth with train-of-four, protect the motionless body from pressure and dry eyes, and — above all — never let a paralyzed patient go under-sedated. Get that discipline right in the ICU and you carry it straight into the operating room.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.